Concepedia

Colleen Brown

CB

11

Publications

684

Citations

11

H-Index

2001

Active since

Affiliations

Pfizer (United States)(Current)

University of California, San Francisco

Bayer (United States)

Colleen Brown is an author at Pfizer (United States) specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

2001–2020

11

Publications

11

Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple Myeloma

Cesar Sommer, Bijan Boldajipour, Tracy C. Kuo et al. · Molecular Therapy · 2019 · 156 citations · Full text

Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab

Sherman M. Chin, Christopher R. Kimberlin, Zygy Roe-Žurž et al. · Nature Communications · 2018 · 143 citations · Full text

Anti–IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function

Li‐Fen Lee, Kathryn Logronio, Guang Huan Tu et al. · Proceedings of the National Academy of Sciences · 2012 · 133 citations · Full text

, , +27

A novel CXCR4 antagonist IgG1 antibody (PF-06747143) for the treatment of hematologic malignancies

Shu‐Hui Liu, Yin Gu, Bernadette Pascual et al. · Blood Advances · 2017 · 50 citations · Full text

Versatile Expression System for Rapid and Stable Production of Recombinant Proteins

M.‐S. Cho, Helena Yee, Colleen Brown et al. · Biotechnology Progress · 2003 · 44 citations

Rows per page

1–5 of 11